Navigation Links
Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options
Date:7/25/2008

WASHINGTON, July 25 /PRNewswire/ -- Klafter & Olsen LLP has filed a class action lawsuit against ArthroCare Corporation ("ArthroCare" or the "Company") (Nasdaq: ARTC) and certain of its officers in the U.S. District Court for the Western District of Texas on behalf of all persons or entities who purchased the common stock ArthroCare from January 24, 2008 through July 18, 2008 (the "Common Stock Purchaser Class Period") and all persons or entities who purchased call options or sold put options in ArthroCare common stock from October 27, 2006 through July 18, 2008 (the "Options Holders Class Period"). As described below, if you purchased these ArthroCare publicly traded securities during the appropriate Class Period, you have 60 days from today to move to be appointed as a Lead Plaintiff.

IF YOU PURCHASED THESE SECURITIES DURING THE APPROPRIATE CLASS PERIOD DESCRIBED ABOVE, YOU ARE NOT COVERED BY ANY OTHER PENDING CLASS ACTION AGAINST ARTHROCARE.

ArthroCare is a medical device company that develops, manufactures and markets minimally invasive surgical products. Before the market opened on Monday, July 21, 2008, ArthroCare announced that it would be restating its previously reported financial results from the third quarter 2006 through the first quarter 2008 because it improperly recognized revenue from DiscoCare, Inc., State of the Art Medical Products, Boracchia & Associates and Clinical Technology, Inc. As a result, ArthroCare indicated that it expects ArthroCare's reported revenue in 2006 will be reduced by $4 million to $7 million, and that for 2007, reported revenue will be reduced by $20 million to $25 million. Further, ArthroCare revealed on July 21, 2008 that reported revenue for the first quarter of 2008 will be reduc
'/>"/>

SOURCE Klafter & Olsen LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Dataline Announces Participation in Operation Golden Phoenix
2. Hoag Hospital Announces Agreement to Open Irvine Campus
3. ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call
4. The Connecticut Hospice, Inc. Announces the Arrival of Six Nurse Scholars From The Henrietta Szold-Hadassah-Hebrew University School of Nursing
5. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
6. Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer
7. BD Announces Results for Third Fiscal Quarter
8. Gerbig Engineering Announces Availability of Cleanroom Utility Panel
9. The Palomino Group Announces Launch of Meeting Support Services Business Unit
10. Misys Announces Preliminary Results for the Year Ended 31 May 2008
11. Cardiome Announces Preferred Share Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...on January 8, 2009 , , TORONTO, Nov. 21 /PR... ("MedEmerg") (OTCBB: MDER), one of Canada,s leadi...hat it has obtained an interim order from the Onta...ously announced plan of arrangement (the "Arrangem...M") will acquire all of MedEmerg,s outstanding sha...
(Date:11/21/2008)...l/ -- The Providence Service,Corporation (Nasdaq:...e Company,s,Chief Operating Officer, has been app...Norris, appointment fills the vacancy left by the ...returns the board to six members. Mr.,Norris wil... Mr. Norris, age 41, has been with Providence sin...
(Date:11/21/2008)... The University of Texas M. D. Anderson Cancer C...rt to eradicate breast cancer in Panama through th...arch of the Americas today at an event with Laura ...ian Fernandez de Torrijos, the First Lady of Panam...tive are the U.S. Department of State and Susan G....
(Date:11/21/2008)...al membership of the Medical,Advertising Hall of ...r Annual,Awards Dinner to be held February 10, 20...hievement Award will also be given. , The 2... Fame are: , Ronald Pantello, who began his adv...r & Hennessey. In 1980 he left Sudler & He...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...utionary weapon for the war against the bulges and...tates. Alli- a fat blocker is the first FDA appro...ithout a prescription. The prescription diet drug ...store shelves with a new name and in nonprescripti...
...o Springs community of U.S is waiting with bated b...e if any person has contracted TB from a young nu...to health officials, tuberculosis has been found r...a Dangol, a young Nepalese student at Colorado Sp...
...that men spends more waking time thinking about...subject in equal measure once the lights are out. ...ecades, the canadian research team report that abo...am reports from both genders contain some form of ...
... at the La Jolla Institute for Allergy & Immunolog...entually lead to a new therapeutic approach for tr...as rheumatoid arthritis, colitis, psoriasis and ot...atory mice, demonstrated the role of retinoic acid...
Other Medicine News:Health News:Alli- a New Weapon for War Against the Bulges 2Health News:Fears Of Spread Of TB After Students Death 2Health News:Equality Among Genders in Terms of Sex Dreams 2Health News:New Therapeutic Approach for Autoimmune and Inflammatory Diseases 2
(Date:11/20/2008)...November 20 Arpida (SWX:...ugs Advisory Committee of the,U.S. Food and Drug ...,approval of intravenous iclaprim, an antibiotic ...ients with complicated skin and skin structure inf...cillin-resistant Staphylococcus,aureus (MRSA). ,...
(Date:11/20/2008)...0 Bionovo, Inc.,(Nasdaq...lts from the Phase 1B,clinical trial of their lea...ancer, BZL101, at the Society for Integrative Onco... Georgia. The Company,s oral presentation was sel...nted as a part of the Best of the,SIO Session on ...
(Date:11/20/2008)... Radius Health ("Radius") announced...n to its second institutional financing round, inc... and the total amount raised since the company,s i...onal investors participated in the financing, led ... Capital, The Wellcome Trust, HealthCare Ventures,...
(Date:11/20/2008)...e-FirstCall/ -- PAREXEL International Corporation ...cal services provider, today announced that it has...ory consulting and clinical research capabilities.... has locations throughout five important biopharma...ude Argentina, Brazil, Chile, and Mexico. This exp...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Emageon Receives Best in KLAS Cardiology PACS Award 15216 1Emageon Receives Best in KLAS Cardiology PACS Award 15216 2QMed Inc Reports Year End and Fourth Quarter Results 15213 1QMed Inc Reports Year End and Fourth Quarter Results 15213 2QMed Inc Reports Year End and Fourth Quarter Results 15213 3QMed Inc Reports Year End and Fourth Quarter Results 15213 4QMed Inc Reports Year End and Fourth Quarter Results 15213 5QMed Inc Reports Year End and Fourth Quarter Results 15213 6QMed Inc Reports Year End and Fourth Quarter Results 15213 7Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 1Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 2NCPA Statement on Californias Delay of E Pedigree Implementation 15207 1NCPA Statement on Californias Delay of E Pedigree Implementation 15207 2
...ase History Highlighted in AACR Cancer Journal , A...gen,Therapeutics, Inc. (NASDAQ:INGN) announced tod... clinical benefit of its lead product,Advexin in a...n as,Li-Fraumeni Syndrome (LFS), a genetic disorde...tumor suppressor gene. This is the,first reported ...
...SLO, Norway, 30 May 2007 - Algeta ASA (OSE: ALGETA...unces that Professor,Øyvind Bruland, of the...geta, will present a Poster and Discussion entitle...one refractory,prostate cancer (HRPC): Results fro...," at the American Society of,Clinical Oncology,s ...
Other Medicine Technology:Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4Algeta to Present Phase II Clinical Study Data for Alpharadin in,Prostate Cancer at ASCO 2
3 mm, 130 degree upwards cutting, detachable.
Sabre 180 is a powerful niche generator.
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator.
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag.
Medicine Products: